W Sekundo1, T Bertelmann, S Schulze. 1. Augenklinik, Philipps Universität Marburg sowie Universitätsklinikum Gießen und Marburg GmbH, Standort Marburg, Baldinger Str., 35043, Marburg, Deutschland, sekundo@med.uni-marburg.de.
Abstract
BACKGROUND: Overview of the retropupillary implantation of iris claw intraocular lenses (Artisan®,Ophtec, Groningen, Niederlande and Verisyse(TM),AMO, Santa Ana CA). MATERIAL AND METHODS: A literature search and review of implantation techniques, patient selection, potential complications and management strategies. RESULTS: This approach has the advantage of a simple implantation technique, an anatomically correct implantation site (as compared to endocapsular implantation) and a relatively low complication rate. An intact iris is, however, a prerequisite for this technique. Ischemic vitreoretinopathies, such as diabetes or vascular occlusive entities, as well as uveitis might be considered as contraindications. CONCLUSIONS: The retropupillary implantation of iris claw intraocular lenses is an interesting and especially time-effective rehabilitation technique for aphakia.
BACKGROUND: Overview of the retropupillary implantation of iris claw intraocular lenses (Artisan®,Ophtec, Groningen, Niederlande and Verisyse(TM),AMO, Santa Ana CA). MATERIAL AND METHODS: A literature search and review of implantation techniques, patient selection, potential complications and management strategies. RESULTS: This approach has the advantage of a simple implantation technique, an anatomically correct implantation site (as compared to endocapsular implantation) and a relatively low complication rate. An intact iris is, however, a prerequisite for this technique. Ischemic vitreoretinopathies, such as diabetes or vascular occlusive entities, as well as uveitis might be considered as contraindications. CONCLUSIONS: The retropupillary implantation of iris claw intraocular lenses is an interesting and especially time-effective rehabilitation technique for aphakia.
Authors: K Schöpfer; A Berger; C Korb; B M Stoffelns; N Pfeiffer; W Sekundo Journal: Graefes Arch Clin Exp Ophthalmol Date: 2012-04-19 Impact factor: 3.117
Authors: Johannes Gonnermann; Necip Torun; Matthias K J Klamann; Anna-Karina B Maier; Christoph V Sonnleithner; Antonia M Joussen; Peter W Rieck; Eckart Bertelmann Journal: Graefes Arch Clin Exp Ophthalmol Date: 2012-12-19 Impact factor: 3.117